Aliquots - Research Briefs

November 13, 2015

Computer extracts cancer stage

Vanderbilt investigators developed a computerized natural language processing algorithm to extract cancer stages from electronic medical records.

By Paul Govern
November 12, 2015

Immune system a must for kidney repair

A signaling protein that is essential for recovery from acute kidney injury works by increasing the population of tissue-repairing immune cells.

By Lorena Infante
November 4, 2015

Detect and defend against pathogens

Understanding factors, such as the receptor TLR9, that detect and defend against pathogens may lead to therapeutic approaches that promote an effective immune response to treat infections.

By Leigh MacMillan
November 2, 2015

Medicaid access state by state

Clinics with more non-physician clinicians are associated with better access for Medicaid patients and lower prices for office visits, according to a recent study.

By Paul Govern
October 30, 2015

Prenatal folic acid and asthma

The timing of folic acid-containing prescription filling during pregnancy was associated with childhood asthma, according to a new Vanderbilt study.

By Leigh MacMillan
October 29, 2015

Inflammation, obesity and diabetes

Vanderbilt study adds to the mounting role for inflammatory signaling in obesity.

By Leigh MacMillan
October 21, 2015

Biomarker for intestinal tumors

A new marker could be useful for diagnosing and treating neuroendocrine tumors of the small intestines.
By Leigh MacMillan
October 20, 2015

A bundle, a dashboard and lasting pneumonia reduction

A “bundle” of electronically implemented care guidelines reduced intensive care unit patient complications related to mechanical ventilation.
By Paul Govern
October 16, 2015

Healing without scarring

Drugs that inhibit the Wnt signaling pathway can regenerate injured skin and may be useful in treating fibromatosis, degenerative joint disease and cancer.
By Sanjay Mishra
October 15, 2015

Risk of death in the ICU

The irregular heart rhythm atrial fibrillation increases the risk of death in patients in the intensive care unit.
By Bill Snyder
October 7, 2015

Rational design of novel antifungals

Structural and molecular details of an anti-fungal target's interaction with inhibitors suggest ways to design better treatments for fungal infections.
By VUMC News and Communications
October 5, 2015

Potential target for lung cancer therapy

The glutamine transporter protein appears to contribute to the survival of lung cancer cells, suggesting it may be a useful diagnostic biomarker and target for therapies.
By Leigh MacMillan
October 2, 2015

The yin and yang of COX-2

New findings add to the understanding of how the enzyme COX-2 works, which is critical to the development of COX-2-targeted anti-inflammatory drugs.
By Sanjay Mishra